US BANCORP \DE\

Bank

Position in PGEN — Precigen, Inc.

CIK 36104 MINNEAPOLIS, MN

Position in PGEN

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$570,000

+$569,757 QoQ

Shares Held

100,000

+135035.1% QoQ

Ownership

0.028%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#89

of 210 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

US BANCORP \DE\ holds $83,094,208 across 214 Biotechnology names. PGEN ranks #20 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	66,580	$16,296,786
2	VRTX	Vertex Pharmaceuticals Inc / Ma	32,020	$15,905,293
3	TECH	BIO-TECHNE Corp	137,966	$9,747,297
4	REGN	Regeneron Pharmaceuticals, Inc.	5,330	$3,323,466
5	ARGX	Argenx SE	3,495	$3,242,555
6	ARWR	Arrowhead Pharmaceuticals, Inc.	38,226	$3,115,799
7	JAZZ	Jazz Pharmaceuticals plc	10,103	$2,434,518
8	GMAB	Genmab A/S	88,420	$2,428,896

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$570,000	100,000	+135035.1%	Shares	Defined	2026-08-12
2025-09-30	$243	74	-91.0%	Shares	Defined	2025-11-12
2025-03-31	$1,229	825	+65.7%	Shares	Defined	2025-05-08
2022-06-30	$667	498	0.0%	Shares	Defined	2022-08-01
2022-03-31	$1,050	498	-42.2%	Shares	Defined	2022-05-11
2021-12-31	$3,198	862	0.0%	Shares	Defined	2022-02-11
2021-09-30	$4,301	862	0.0%	Shares	Defined	2021-11-10
2021-06-30	$5,620	862	-18.8%	Shares	Defined	2021-08-05
2021-03-31	$7,317	1,062	+23.2%	Shares	Defined	2021-04-28
2020-12-31	$8,792	862	0.0%	Shares	Defined	2021-02-04
2020-09-30	$3,017	862	-53.7%	Shares	Defined	2020-11-10
2020-06-30	$9,291	1,862	+24.3%	Shares	Defined	2020-08-07
2020-03-31	$5,093	1,498	—	Shares	Defined	2020-05-13
No filing history on record for this holder in this stock.